NCT01462292 A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase PHASE2
NCT01459315 GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01458366 Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide Status COMPLETED Phase PHASE1/PHASE2
NCT01458132 Drug Exposure Registry for GSK2248761, an Investigational NNRTI Status COMPLETED Phase N/A
NCT01458067 A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency Status COMPLETED Phase PHASE1
NCT01458054 Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults Status COMPLETED Phase PHASE1
NCT01457989 Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304 Status COMPLETED Phase N/A
NCT01457950 A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab Status COMPLETED Phase PHASE3
NCT01457924 Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01457560 Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine Status COMPLETED Phase PHASE3
NCT01457547 Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course Status COMPLETED Phase PHASE4
NCT01457508 Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately Status COMPLETED Phase PHASE3
NCT01457495 Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly Status COMPLETED Phase PHASE2
NCT01456936 Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders Status COMPLETED Phase PHASE4
NCT01455051 Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation Status COMPLETED Phase PHASE2
NCT01454479 A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma Status UNKNOWN Phase PHASE1
NCT01453998 Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) Status COMPLETED Phase PHASE2
NCT01453491 A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE1